| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $571.0M | -72.6% |
| Cost of Revenue | $405.0M | -58.5% |
| Gross Profit | $166.0M | -85.0% |
| R&D Expense | $194.0M | -6.7% |
| SG&A Expense | $116.0M | -29.7% |
| Operating Income | -$398.0M | -8.4% |
| Pre-tax Income | -$383.0M | -9.1% |
| Income Tax | $1.0M | -90.0% |
| Net Income | -$384.0M | -6.4% |
| EPS (Basic) | -$0.57 | +0.0% |
| EPS (Diluted) | -$0.57 | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $506.0M | -49.9% |
| Short-term Investments | $213.0M | +42.0% |
| Current Assets | $777.0M | -36.5% |
| Total Assets | $799.0M | -37.7% |
| Current Liabilities | $309.0M | -31.2% |
| Total Liabilities | $322.0M | -30.8% |
| Stockholders' Equity | $477.0M | -41.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$422.0M | +55.6% |
| Capital Expenditures | $2.0M | +0.0% |
| Investing Cash Flow | -$47.0M | -1466.7% |
| Financing Cash Flow | -$22.0M | -414.3% |
| Free Cash Flow | -$424.0M | +55.5% |